Dr. Angelo Seby M.D.

Dr. Angelo Seby MD, MACP, currently serves as the Director of Clinical Safety and Pharmacovigilance at Ocugen since March 2022, with a strong emphasis on signal detection, aggregate reporting, and risk management in clinical safety. Prior roles include Medical Director at Bioclinica, where responsibilities encompassed medical safety for assigned products, regulatory correspondence with the FDA and EMA, and leading the Pharmacovigilance Core Team. Dr. Seby also held Associate Director positions at Parexel and Red Nucleus, focusing on signal detection and risk management, and worked as a Clinical Safety Physician at Pfizer. Educational credentials include a Doctor of Medicine from Odessa National Medical University and multiple advanced certifications in pharmacovigilance and clinical trials from prestigious institutions.